News and Updates

Type 1 diabetes (T1D) can be hard to predict in high risk children. Testing for the presence of T1D autoantibodies—antibodies against one’s own proteins—helps reduce the incidence of diabetic ketoacidosis (DKA)—a common occurrence in children upon diagnosis, that can lead to death if not treated—but this testing is not widely available. While having 2 or […]

Beta cell replacement therapies for type 1 diabetes (T1D) have made significant advances in just the past 10 years. We now have insulin-producing beta cells, derived from stem cells, which makes a donor (needed to provide the beta cells) obsolete. We have seen that stem cell-derived precursors can—once implanted in humans—mature into beta cells and […]

Back to school season during the coronavirus pandemic has been met with several challenges, but for college students, preparation is still key, whether on-campus or at home.

Three teachers with type 1 diabetes (T1D) share their perspectives about back-to-school, including their biggest concerns and what they want parents to know.

Our bold vision for the future outlines strategies to drive greater impact to unlock cures and drive research that improves the lives of people with type one diabetes (T1D).

On July 24, the White House released three Executive Orders related to drug pricing.

Healthcare and education professionals share what parents and educators need to know for a return to school during the COVID-19 pandemic.

Just in time for Parents’ Day, we’re highlighting the ways parents and guardians rise to the challenge of helping kids live with and learn to manage type 1 diabetes.

It’s been around the news: COVID-19 might trigger diabetes, at least in some people. That’s what several Breakthrough T1D-funded scientists posit. But let’s look at the evidence.

Two leaders from Tandem Diabetes Care share real-world outcomes from Tandem insulin pump users, other practical insights.